Chesapeake Energy CKD claims they want to spin off or sell its oilfield-services. The company has raised more than $11 billion over the past 24 months selling holdings, drilling sites, ownership in shale fields and its natural gas pipelines. The Wall Street Journal in a story Wednesday quoted UBS analyst Bill Featherston who believes that spinning out the oilfield-service unit into a separately traded company is the more likely scenario than an outright sale.

Apparently this is due to the fact that most oilfield-service companies don't want to buy other company's equipment. They'd rather build their own than buy rusty, aging rigs and pressure-pumping devices. That's the way Nabors Industries, NBR does it, not to mention Schlumberger SLB. Last year Chesapeake Oilfield Services had total revenue of nearly $2.2 billion. A spin off would be shareholder friendly and would also help the company pay down its large debt load.

The news about Tenet Healthcare THC was worse than anticipated. Although the earnings report and a downgrade or two can tank a stock, the news wasn't all bad. Analysts expected a profit of 34 cents a share, according to Thomson Reuters I/B/E/S. The company reported a net loss of $24 million, or 24 cents a share, down year over year from a net income of $49 million, or 45 cents a share. Net operating revenue increased 67% to $3.89 billion. Adjusted EBITDA, excluding items, increased 32.1% year over year to $444 million from $336 million.

As I recently wrote in my own article on THC, this company has to face some nasty allegations from the Department of Justice and others in the form of a lawsuit pending against them. Before you buy the stock, please read my article. At some point the share price will be so low that traders and speculators will be tempted.

My comments about Medtronic MDT as an emerging, "new" company are well worth the read in this article posted today. The longer-term outlook for MDT is encouraging to say the least. The company has had some recent disappointments, but isn't that what makes for a set-up for a good buying opportunity?

Patience is a virtue of a "stock jockey". Remember, we jockeys don't ride wild, untamed stallions. We wait for the thoroughbreds that are tested, rested, and ready to win the right race at the right time. When it comes to these 3 companies, all I can conclude is "get ready, get set, not quite yet". Use your own discretion and remember not to buy all your shares at one time. Accumulating is a stock jockey's best "saddle" and riding style.